Rapid CD45.2 Labeling and Tissue Analysis
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : National Institutes of Health
Protocol cited in 2 other protocols
Variable analysis
- Retroorbital injection of 2.5 μg of CD45.2 FITC in 100 μl PBS
- Total number of viable cells in each tissue (spleen, lungs, and mediastinal lymph nodes (mLN))
- Time between injection and euthanasia (3 minutes)
- Tissue isolation and processing (aseptic isolation and processing as previously described [12])
- Tissue processing methods (passing spleens and mLNs through a 70 μM cell strainer, mincing and digesting lungs with Liberase, lysing red blood cells in spleen and lung using ACK lysis buffer)
- Viable cell counting method (trypan blue exclusion using a TC10 Automated Cell Counter)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!